Related Experiment Video
Updated: Jun 16, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
Id2 deficiency promotes metastasis in a mouse model of ocular cancer
Olga A Agapova1, Erica Person, J William Harbour
1Department of Ophthalmology & Visual Sciences and Siteman Cancer Center, Washington University School of Medicine, Campus Box 8096, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
Abstract:
The inhibitor of DNA binding 2 (Id2) basic helix-loop-helix protein interacts genetically and physically with the pocket proteins (Rb, p107 and p130) and has been implicated as an oncogene. In other studies, however, Id2 has been shown to function as a tumor suppressor. Here, we studied the role of Id2 in a well characterized model of ocular cancer in which the three pocket proteins are inactivated by generating mice lacking one or both Id2 alleles. Id2 deficiency had no impact on tumorigenesis in the eye. Unexpectedly, however, Id2 loss significantly increased the rate of metastasis. Liver metastases in Id2 heterozygotes demonstrated significant decrease of Id2 expression and loss of the remaining Id2 allele, strongly suggesting that Id2 inactivation specifically was required for metastasis in this model. These findings provide new insights into the role of Id2 in metastasis.
Insights
Inhibitor of DNA binding 2 (Id2) loss did not affect ocular tumor growth but unexpectedly increased metastasis. Id2 inactivation was specifically required for metastasis in this cancer model.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The role of Inhibitor of DNA binding 2 (Id2) in cancer is controversial, with studies suggesting both oncogenic and tumor-suppressive functions.
- Id2 interacts with pocket proteins (Rb, p107, p130), which are crucial regulators of the cell cycle.
Purpose of the Study:
- To investigate the role of Id2 in ocular cancer using a mouse model where pocket proteins are inactivated.
- To determine the impact of Id2 deficiency on tumorigenesis and metastasis in this model.
Main Methods:
- Generation of mice lacking one or both Id2 alleles in a well-characterized model of ocular cancer.
- Analysis of tumor growth and metastatic potential in Id2-deficient mice.
- Assessment of Id2 expression in liver metastases.
Main Results:
- Id2 deficiency did not influence primary ocular tumor development.
- Loss of Id2 significantly accelerated the rate of metastasis.
- Liver metastases showed reduced Id2 expression and loss of the remaining Id2 allele, indicating selection for Id2 inactivation.
Conclusions:
- Id2 functions as a tumor suppressor in the context of metastasis, not primary tumor formation, in this ocular cancer model.
- Specific inactivation of Id2 is a critical step for metastasis in this model.
- These findings offer new insights into the complex role of Id2 in cancer progression and metastasis.
More Related Videos
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
08:47Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells
Published on: August 21, 2012